お知らせ －News
Launch of SunShell Peptide C9 and SunShell Protein C8
ChromaNik Technologies has launched SunShell Peptide C9 and SunShell Protein C8, new bio-molecule-oriented columns designed to improve separation performance and reproducibility of peptides and proteins in LC-MS analysis.
The specifications are as follows.
SunShell Peptide C9
Particle size: 2.6 μm (core diameter: 1.6 μm)
Pore size: 16 nm
Carbon load: 2.5%
Bonded phase: Hexafunctional C18
Inertization:
Sunniest end-capping + proprietary advanced inert treatment to suppress non-specific adsorption
Feature:
- By reducing the carbon load to half while maintaining the same base material and bonding density as SunShell Peptide C18, this column provides distinct selectivity and alternative separation behavior.
- The introduction of a multifunctional bonding chemistry significantly enhances acid stability.
SunShell Protein C8
Particle size: 3.4 μm (core diameter: 3.0 μm)
Pore size: 16 nm
Carbon load: 0.5%
Bonded phase: C8
Inertization:
Sunniest end-capping + proprietary advanced inert treatment to suppress non-specific adsorption
Feature:
- This column employs a balanced design combining thin porous-shell core-shell particles and a wide-pore substrate, enabling both effective separation and smooth elution of proteins.
- Advanced end-capping ensures compatibility with high-temperature operating conditions.
These columns are derivative products of the SunShell Peptide C18, launched in 2024, and are manufactured using the same advanced inertization technology.
By effectively minimizing adsorption, they support LC-MS analysis across a broad range of targets, from moderately to highly hydrophobic peptides and proteins.
For full details on the SunShell Peptide C18 series lineup and pricing, please refer to the dedicated brochure [PDF].
Thank you for your continued interest.